# Implicity

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/implicity

- Industry: Software
- Headquarters: Montrouge, France
- Website: www.implicity.fr
- Total disclosed funding: $65M
- Investors on record: 8

## About

Implicity is a French technology company focused on innovating software solutions for the remote monitoring and management of cardiac devices, enhancing patient care and data analysis for healthcare providers.Founded in 2016 in Montrouge, France, Implicity develops advanced software for remote cardiac device monitoring. The company has executed a total of 3 deals, with its most recent funding round being a Series A in March 2022, during which they raised EUR 18 million, led by Credit Mutuel Equity with participation from BNP Paribas Développement, Bpifrance, Karista, Serena, and XAnge. The CEO and co-founder, Arnaud Rosier, has a background in technology innovation, contributing to the firm's growth and strategic direction.Implicity specializes in software solutions for the remote monitoring and data management of cardiac devices. Their platform supports secure transmission and analysis of patient data, facilitating real-time cardiovascular health monitoring by healthcare providers. The software addresses challenges in managing extensive cardiac device data, aiding hospitals and clinics in Europe and North America to enhance patient care and operational efficiency.Implicity operates on a subscription-based revenue model, allowing healthcare institutions to access its remote monitoring platform. Clients receive tiered service agreements that include data analytics and patient management tools, tailored to their needs. Revenue is further bolstered by partnerships with medical device manufacturers, enabling a comprehensive service offering for cardiac monitoring technologies.Following the EUR 18 million Series A funding round in March 2022, Implicity plans to utilize these resources to expand its presence in the US market and other new geographic regions. The company intends to develop additional software solutions for medical devices, aiming to enhance their product offerings and market reach in the coming years.

## Funding rounds

- Round, Sep 10, 2026, $41M — IRIS, Five Arrows
- Series A, Mar 16, 2022, $20M — Credit Mutuel Equity, Karista, XAnge, Bpifrance, Serena, BNP Paribas Developpement
- Series A, Feb 28, 2019, $4.5M — Karista, XAnge, Serena

## Investors

- Karista (https://capitalatlas.ai/funds/karista) — Series A
- XAnge (https://capitalatlas.ai/funds/xange) — Series A
- Serena (https://capitalatlas.ai/funds/serena) — Series A
- Credit Mutuel Equity (https://capitalatlas.ai/funds/credit-mutuel-equity) — Series A
- Bpifrance — Series A
- BNP Paribas Developpement (https://capitalatlas.ai/funds/bnp-paribas-developpement) — Series A
- IRIS (https://capitalatlas.ai/funds/iris)
- Five Arrows (https://capitalatlas.ai/funds/five-arrows)